3.75% -0.0059

Kintara Therapeutics Inc (KTRA)

Overview News Price History Financials Why KTRA Down? Discussions Forecast Stock Split

Why is Kintara Therapeutics Inc (KTRA) Stock down?

We've noticed a 5.82% decline in Kintara Therapeutics Inc (KTRA) stock during the 2024-04-26 trading session. While this could be attributed to normal volatility or various internal and external factors, please be aware that we are actively monitoring the situation, and we'll provide timely updates as soon as possible!

31 Oct, 2023:

Kintara Therapeutics Stock (KTRA) dropped by 79.68% from $3.76 to $0.764 in the trading on Tuesday October 31, 2023. The reason why KTRA stock down today is due to VAL-083 failure. The company has announced that their drug VAL-083 did not outperform existing treatments for glioblastoma, a severe brain cancer. Kintara is discontinuing the development of VAL-083 and shifting their focus to REM-001, a localized tumor treatment. Kintara will also explore strategic options to maximize shareholder value.